Synaptrix
NY - New YorkBiotechnology
Focus: Synaptrix is a public biotechnology company focused on brain-computer interface (BCI) technologies for neurological indications, headquartered in New York. The company operates at an early stage with minimal clinical trial activity (2 total trials) and no approved products.
Profile data last refreshed 17h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Synaptrix?
AI assessmentSynaptrix is a high-risk, high-reward early-stage play for researchers seeking frontier neurotech exposure, but career stability depends heavily on unverified financial health and clinical progress.
Why Work Here
- Frontier technology platform in BCI with potential for transformative neurological applications
- Public company status provides liquidity and potential equity upside in emerging neurotech space
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Intervention/Treatment
Neurologic DisorderClinical Trials (1)
NCT06169696EMPOWER Early Feasibility Study: Non-invasive BCI to Control a Wheelchair for People With Paralysis
N/AHelp build intelligence for Synaptrix
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.